TY - JOUR
T1 - Enhanced serum response element binding activity correlates with down-regulation of c-fos mRNA expression in the rat brain following repeated cortical lesions
AU - Ivkovic, Sanja
AU - Kanazir, Selma
AU - Rakic, Ljubisav
AU - Ehrlich, Michelle E.
AU - Ruzdijic, Sabera
N1 - Funding Information:
This work was supported by National Institute of Mental Health Grants 47028 and 00945 (M.E.E.) and also by grants from the Serbian Ministry of Science (No. 0309) and the Vivian L. Smith Foundation for Restorative Neurology, Houston, TX. We are grateful to Dr. Edward B. Ziff for his comments and suggestions.
PY - 1997/12/1
Y1 - 1997/12/1
N2 - Repeated lesions of rat cerebral cortex result in transient peaks in the level of the c-fos transcript, but after the second lesion, this peak is substantially diminished. Using this lesion paradigm, we have analyzed the participation of the c-fos promoter elements SRE and DSE in the regulation of c-fos transcription. Following a single lesion, SRE/DSE binding activity peaked at 2 h, subsequent to the maximal levels of c-fos mRNA and parallel to the peak of c-Fos protein. After a second lesion (reinduction), 4 h following the initial lesion, SRE/DSE binding activity peaked after only 30 min and was significantly higher than following the first lesion. Once again, this peak occurred after the peak of c-fos mRNA expression and parallel with the second peak of c-Fos protein expression. These results suggested that the SRE and DSE promoter elements participated in the induction and down-regulation of c-fos transcription in vivo and suggested the possible involvement of Fos protein in its own regulation. The ability of Fos/Fra proteins to participate in a transcriptional complex was confirmed in gel-shift experiments with an AP-1 element, and the biphasic trend of binding activity was observed. Supershift experiments were performed to directly determine whether Fos protein was participating in SRE and/or DSE transcriptional complexes. No alterations in the position or intensity of the shifted band were observed using Fos/Fra antiserum suggesting that Fos/Fra proteins could be involved in c-fos down-regulation through mechanisms other than direct participation in the SRE/DSE transcription complex.
AB - Repeated lesions of rat cerebral cortex result in transient peaks in the level of the c-fos transcript, but after the second lesion, this peak is substantially diminished. Using this lesion paradigm, we have analyzed the participation of the c-fos promoter elements SRE and DSE in the regulation of c-fos transcription. Following a single lesion, SRE/DSE binding activity peaked at 2 h, subsequent to the maximal levels of c-fos mRNA and parallel to the peak of c-Fos protein. After a second lesion (reinduction), 4 h following the initial lesion, SRE/DSE binding activity peaked after only 30 min and was significantly higher than following the first lesion. Once again, this peak occurred after the peak of c-fos mRNA expression and parallel with the second peak of c-Fos protein expression. These results suggested that the SRE and DSE promoter elements participated in the induction and down-regulation of c-fos transcription in vivo and suggested the possible involvement of Fos protein in its own regulation. The ability of Fos/Fra proteins to participate in a transcriptional complex was confirmed in gel-shift experiments with an AP-1 element, and the biphasic trend of binding activity was observed. Supershift experiments were performed to directly determine whether Fos protein was participating in SRE and/or DSE transcriptional complexes. No alterations in the position or intensity of the shifted band were observed using Fos/Fra antiserum suggesting that Fos/Fra proteins could be involved in c-fos down-regulation through mechanisms other than direct participation in the SRE/DSE transcription complex.
KW - C-fos gene autoregulation
KW - C-fos gene expression
KW - Cortical lesion
KW - Desensitization
KW - Down-regulation
KW - Serum response element
UR - http://www.scopus.com/inward/record.url?scp=0030728760&partnerID=8YFLogxK
U2 - 10.1016/S0169-328X(97)00222-2
DO - 10.1016/S0169-328X(97)00222-2
M3 - Article
C2 - 9450678
AN - SCOPUS:0030728760
SN - 0169-328X
VL - 52
SP - 62
EP - 70
JO - Molecular Brain Research
JF - Molecular Brain Research
IS - 1
ER -